August 16, 2006
For Immediate Release
Biomaterials Inducing Growth in Orthopedics (MedMarkets)
FOOTHILL RANCH, CA — The worldwide market for orthopedic devices and materials is growing at a steady 8%, but one of the fastest growing segments is orthopedic biomaterials, with sales increasing at a projected 15% per year, according to the August 2006 issue of MedMarkets from MedMarket Diligence.
Aggregate sales of $4.6 billion for the orthopedic biomaterials segment are comprised of grafts (allografts, autografts), polymers, (PVC, PMMA, PLLA, etc.), ceramics, surgical glues/hemostats/sealants, tissue engineering (bone, tendon, ligament, cartilage) and growth factors (EGF, PDGF, FGF and BMP). Key players in this market include Medtronic Sofamor Danek, Genzyme Biosurgery, Synthes, Osteotech, Fidia and Smith & Nephew.
The August 2006 issue of MedMarkets reviews the status of the market and developments in orthopedic biomaterials, detailing product types, segment revenues and market forecast.
MedMarkets is published 12 times annually by MedMarket Diligence. Coverage encompasses medical device, biotech, biomaterials and the range of technologies encompassing device market developments and analysis of Interventional Cardiology, Cardiovascular Surgery, Orthopedics/Musculoskeletal, Abdominal & Thoracic Surgery, Gynecology, Oncology, Neurology & Neurosurgery and other clinical sectors. Past coverage may be reviewed at www.mediligence.com/archive2006.html.
MedMarket Diligence provides tactical decision-making solutions on medical
technology to the medical products and investment industries. The company
MedMarkets newsletter, a monthly analysis of the market implications of new
medical technologies, and dedicated reports on technology markets. For
additional details, contact Patrick Driscoll at
email or call
949-859-3401 or toll-free (in the U.S.). 1-866-820-1357.